Spandana Sphoorty, 5 Paisa Capital: Financial, Mishtann Foods, 5Paisa Capital, and & Entertainment are among the companies that will announce their quarterly results for the quarter ending June 2022.
Tata Consulting Services: The country’s largest software exporter posted a 5.2% rise in net profit in the June quarter to Rs 9,478 crore, limited by the impact of annual wage hikes and promotions that have squeezed profit margins operating at multi-quarter lows.
Dr. Reddy’s Laboratories: The drugmaker said it launched its generic version of fesoterodine fumarate extended-release tablets used to treat overactive bladder in the US market. The launch follows approval from the United States Food and Drug Administration (USFDA).
Power Grid Corporation of India: The large state-owned electricity company has bagged an interstate transmission project for the evacuation of electricity from Neemuch SEZ in Madhya Pradesh. PGCIL won the project through a tariff-based competitive bidding process.
Fortis Health: The healthcare facilities company aims to add about 1,500 beds over the next five years to bolster its presence in existing facilities, according to its annual report for 2021-22. The healthcare major currently has more than 4,300 operational beds.
Avenue Supermarkets: The D-Mart operator reported more than six times its consolidated net profit at Rs 642.89 crore for the quarter ended June 30, 2022, helped by a “very good recovery” in overall sales and a weak comparative annual basis. The company had posted a net profit of Rs 95.36 crore in the April to June quarter a year ago.
Tata engines: The local auto major said it has raised prices for its range of passenger vehicles with immediate effect to partially offset the impact of rising input costs. A weighted average price increase of 0.55% will take effect from Saturday across the range, depending on variant and model.
Bandhan Bank: Advances from the main lender were up 20% from a year ago to reach Rs 96,649 crore as of June 30, the bank said. The private sector lender’s total deposits also increased by 20% to Rs 93,057 crore at the end of the first quarter of FY23.
Aurobindo Pharma: The drugmaker remains focused on developing complex and differentiated products across multiple areas including oncology, hormonal products, biosimilars, depot injections and vaccines to drive the next phase of growth, according to its annual report for 2021-22.
National Bank of Punjab: The state-run lender will select a firm of actuaries to calculate the intrinsic value of the CHOICE insurance joint venture, in which the public bank must divest its stake in accordance with regulatory requirements. The New Delhi-based lender will open financial bids on July 11, 2022 to select the actuarial firm.
IIFL Wealth Management: The wealth management firm has paid a settlement amount of more than Rs 3 crore to market regulator Sebi to settle a case over breaches of regulatory standards. The company allegedly violated securities brokerage regulations as well as the PFUTP (Prohibition of Fraudulent and Unfair Trading Practices) regulations.
Zydus Life Sciences: The pharmaceutical and pharmaceutical manufacturer has announced that they have launched the generic version of sitagliptin in India under the brand names Sitaglyn and Siglyn to fight type 2 diabetes. better compliance.
Overseas Indian Bank: The public lender increased the marginal cost of the funds-based lending rate by 0.10% for all durations. The new rates, which will come into effect from July 10, will be between 6.95 and 7.55%.
CMMT: The state-owned mining and metallurgical company reported a consolidated net profit of Rs 118.38 crore for the fourth quarter ended March, compared to a loss of Rs 597.17 crore a year ago. During the January to March quarter, its total revenue stood at Rs 2,260.81 crore from Rs 9,314.17 crore.
REC: The public finance company has sought shareholder approval for the issuance of 65.83 crore free shares. These free shares would be issued using capital reserves of Rs 658.30 crore per postal vote. The company offered to issue one new (free) share for holding three existing shares to shareholders.
Monte Carlo Modes: The apparel brand posted revenue growth that doubled by 130% in the April-June quarter of this fiscal year, helped by volume growth and rising prices.